Human Medicine:

Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

Published: 23rd January 2020

SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB UK & Ireland’s Chief Executive, Arnaud Gueny, has issued the following statement:

I am pleased to confirm that, following an evaluation process, the NHS has identified SYNLAB UK & Ireland as their preferred strategic partner to transform and deliver pathology services in South East London.
However, the procurement process is ongoing and no contract has been awarded. For this reason, confidentiality requirements remain in place and we are unable to provide any further information or comment at this time.
We will be pleased to provide more details as soon as the process is concluded.

Arnaud Gueny, Chief Executive for SYNLAB UK and Ireland,
Latest Human Medicine News
Landmark Day for Pathology Partnership with Launch of Synnovis Brand

Published: 4th October 2022 A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a…

Read More (about 'Landmark Day for Pathology Partnership with Launch of Synnovis Brand')
Southwest Pathology Services Celebrates its 10th Anniversary

Published: 17th August 2022 As part of SYNLAB UK & Ireland (‘SYNLAB’), Southwest Pathology Services (‘SPS’) is celebrating the 10th anniversary of its partnership between…

Read More (about 'Southwest Pathology Services Celebrates its 10th Anniversary')
Pathology laboratory becomes the first in the UK to support remote plate reading  

Published: 15th June 2022 A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in…

Read More (about 'Pathology laboratory becomes the first in the UK to support remote plate reading  ')